Globe and Mail

A Stem-Cell-Based Drug Gets Approval in Canada
New York Times
The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation.
World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance
Osiris stem-cell therapy wins Canadian approvalMarketWatch

all 73 news articles »